Yep maybe to short it on results day. Who knows.... Volume has been low. An optimist could put spin on this just like SR does. There won’t be too many companies doing well in 2020. Myx flagged this at last year’s AGM and offered no profit guidance this year. They’ve done nothing to impress their share holders over the last 13 years other than to release Tolsura, create the deal of the century with the Teva acquisition, promise 9.65% of the company to Mithra on their novel E4 untested OCP that will be released in 2021, even though they’ve been banging on about Myring for the last 3 years which is still missing in action. By time E4 gets released unemployment in the States will be staggering as the economy gets walloped by the horrendous mismanagement of the Covid virus which has so far only infected 5 000 000 people out of a 328 000 000 population in the States thanks to the self proclaimed genius...... My guess is people will be far more concerned about paying for food, rent and basic health care than for a brand spanking new OCP with a hefty price tag as Covid continues to devastate economies all over the globe and recessions drift towards a likely worldwide depression. They are called depressions for a very good reason. I’d be filling my Prozac script before my E4 script.
MYX Price at posting:
38.0¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)